Ligasan, Mercidita .
HRN: 26-24-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2024
CEFUROXIME 500MG (TAB)
11/20/2024
11/27/2024
PO
500mg
1 Tab BID X 7 Days
RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes